momo-T/FIF Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

scaram(o)uche

To: Miljenko Zuanic who wrote (12011)	12/28/2018 2:21:36 PM
From: semi_infinite	1 Recommendation of 12215

I suppose it is possible given enough time and bad clinical outcomes. Closing price prior to Roche news was 1.65 and the upfront cash was ~ 1.5 per share so the step change was not based upon non-cash optimism alone. Perhaps this will be in the ~10% of gaps where there is no round trip plus recent market action gave it ample chances for wash out selling. IMO it could a playable bounce FWIW.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next